Published in Health and Medicine Week, June 20th, 2005
New analysis from Frost & Sullivan, "Emerging Therapeutics in the U.S. Colorectal Cancer Market," reveals revenue in this market totaled $1,897 million in 2004 and projects to reach $2,110 million in 2011 but also...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.